NCT02027662View on ClinicalTrials.gov

Therapeutic Equivalence of OsvaRen® Tablets and OsvaRen® Granules

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

June 30, 2015

Conditions
HyperphosphatemiaChronic Kidney Disease
Interventions
DRUG

Osvaren Granules

DRUG

Osvaren film-coated tablets

Trial Locations (11)

22297

Nephrocare Hamburg-Barmbek GmbH, Hamburg

24106

Dialysezentrum, Kiel

24939

Dialysezentrum, Flensburg

35392

Georg-Haas-Dialysezentrum der PHV, Giessen

52074

RWTH University Hospital, Dpt for Nephrology, Aachen

Unknown

Nephro-Studien GbR am Klinikum Erfurt, Erfurt

Dialysezentrum, Hanover

Dialysezentrum, Magdeburg

Dialysezentrum, Minden

Dialysezentrum, Solingen

Dialysezentrum, Velbert

All Listed Sponsors
lead

Fresenius Medical Care Deutschland GmbH

INDUSTRY

NCT02027662 - Therapeutic Equivalence of OsvaRen® Tablets and OsvaRen® Granules | Biotech Hunter | Biotech Hunter